Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 169.90
-2.40 (-1.39%)
At close: Jan 1, 2026
Piramal Pharma Revenue
Piramal Pharma had revenue of 20.44B INR in the quarter ending September 30, 2025, a decrease of -8.83%. This brings the company's revenue in the last twelve months to 89.36B, up 2.66% year-over-year. In the fiscal year ending March 31, 2025, Piramal Pharma had annual revenue of 91.51B with 11.99% growth.
Revenue (ttm)
89.36B
Revenue Growth
+2.66%
P/S Ratio
2.52
Revenue / Employee
16.32M
Employees
5,476
Market Cap
225.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 91.51B | 9.80B | 11.99% |
| Mar 31, 2024 | 81.71B | 10.90B | 15.39% |
| Mar 31, 2023 | 70.82B | 3.47B | 5.16% |
| Mar 31, 2022 | 67.34B | 8.47B | 14.39% |
| Mar 31, 2021 | 58.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.14T |
| State Bank of India | 3.57T |
| Larsen & Toubro | 2.76T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| Bharti Airtel | 1.95T |
| ICICI Bank | 1.91T |